Adenosine A2b Receptor antibody (AA 101-200) (Cy7)

Catalog No. ABIN759542

The Rabbit Polyclonal anti-Adenosine A2b Receptor antibody has been validated for WB, FACS, IF (p) and IF (cc). It is suitable to detect Adenosine A2b Receptor in samples from Human, Mouse and Rat.

Quick Overview for Adenosine A2b Receptor antibody (AA 101-200) (Cy7) (ABIN759542)

Target: Adenosine A2b Receptor (ADORA2B)

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Adenosine A2b Receptor antibody is conjugated to Cy7

Application: Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))

Product Details anti-Adenosine A2b Receptor Antibody (Cy7)

Binding Specificity: AA 101-200

Cross-Reactivity: Human, Mouse, Rat

Predicted Reactivity: Dog,Pig,Rabbit,Guinea Pig

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human ADORA2B

Isotype: IgG

Application Details

Application Notes: FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for Adenosine A2b Receptor

Target: Adenosine A2b Receptor (ADORA2B)

Alternative Name: ADORA2B

Background:

Synonyms: ADORA2, Adenosine receptor A2b, ADORA2B

Background: Receptor for adenosine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.

Gene ID: 136

UniProt: P29275

Pathways: cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process